| Literature DB >> 21776291 |
Maggie C S Ng1, Alice Y M Jones, L C Cheng.
Abstract
Increased heart rate (HR) and reduced blood pressure (BP) are common consequences of cardiac surgery. This study investigated the effect of transcutaneous electrical nervous stimulation applied over acupuncture points (Acu-TENS) on HR, BP, rate pressure product (RPP) and nausea and vomiting score after open-heart surgery. After open heart surgery, 40 patients were randomly allocated to either an Acu-TENS group, which received a 40-min session of TENS applied bilaterally over the acupuncture point PC6 on postoperative days 1-5, or a Placebo-TENS group, which received identical electrode placement but with no electrical output from the TENS unit, despite an output indicator light appearing activated. HR, systolic and diastolic BPs (SBP and DBP) were recorded and RPP computed. Nausea and vomiting symptoms were quantified using a 4-point Likert scale before and after TENS intervention. Daily HR, BP and antiemetic administration data were recorded from a further 20 consecutive subjects who received no intervention and formed the Control group. A trend of decreasing HR and increasing BP in the Acu-TENS group was observed over the five postoperative days, with all variables returning to preoperative values by Day 4 (P > .2). In the Placebo-TENS and Control groups the HR remained higher (P < .0001), BP lower (P < .05) and RPP higher (P = .01) than respective preoperative values at Day 4. The dose of Maxolon required was lowest in the Acu-TENS group (P = .038). We concluded that Acu-TENS facilitated an earlier return to preoperative BP, HR and RPP values in patients after acute heart surgery.Entities:
Year: 2011 PMID: 21776291 PMCID: PMC3135238 DOI: 10.1093/ecam/neq015
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Location of the acupuncture point PC6.
Figure 2Electrode placements over PC6.
Figure 3Consort diagram showing the flow of participants through the trial.
Demographic data and baseline characteristics for the patient groups.
| Acu-TENS ( | Placebo-TENS ( | Control ( |
| |
|---|---|---|---|---|
| Age | 54.88 ± 3.90 | 53.05 ± 2.52 | 59.4 ± 2.28 | .387 |
| Body mass index | 22.90 ± 0.75 | 22.14 ± 0.76 | 24.0 ± 0.92 | .092 |
| Ejection fraction | 64.60 ± 1.52 | 60.40 ± 2.51 | 61.6 ± 1.65 | .294 |
| Duration of operation | 4.05 ± 0.13 | 3.97 ± 0.15 | 4.22 ± 0.24 | .945 |
| Gender (M : F) | 13 : 7 | 7 : 13 | 14 : 6 | .500 |
|
| ||||
| Operation | ||||
| CABG : VR | 9 : 11 | 5 : 15 | 12 : 8 | .138 |
| Metoprolol (mg day−1) | 10.0 ± 2.81 | 5.00 ± 2.29 | 8.3 ± 2.63 | .395 |
| Amiodarone (mg day−1) | 20 ± 13.75 | 20 ± 13.76 | 20 ± 13.72 | .933 |
| ACEi (mg day−1) | 0 | 0.4 ± 0.28 | 0 | .169 |
| Digoxin (mg day−1) | 37.5 ± 20.48 | 75 ± 26.28 | 25 ± 17.21 | .244 |
Data are mean ± SE. M: male; F: female; CABG: coronary artery bypass graph; VR: valve replacement.
Comparison of mean HR, SBP and RPP before and at postoperative Day 4.
| Acu-TENS group | Placebo-TENS group | Control group | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Pre-op | Day 4 |
| Pre-op | Day 4 |
| Pre-op | Day 4 |
| |
| Heart rate (beat min−1) | 74.2 (2.41) | 75.8 (2.36) | .53 | 72.0 (1.43) | 87.3 (1.82) | .000 | 63.4 (2.38) | 83.03 (2.12) | .000 |
| SBP (mmHg) | 111.9 (3.64) | 115.9 (2.94) | .21 | 114.6 (2.64) | 106.9 (1.69) | .015 | 113.3 (3.95) | 109.1 (1.93) | .016 |
| Rate pressure product | 8289.8 (358.9) | 8740.9 (282.6) | .21 | 8261.6 (275.3) | 9220.7 (352.0) | .008 | 7699.3 (353.5) | 9344.5 (368.6) | .000 |
Data are mean ± (SE).
Figure 4Mean resting heart rate at pre- and post-operation days.
Figure 5Mean SBP at pre- and post-operation days.
Figure 6Mean rate pressure product at pre- and post-operation days.
Between group comparison of mean difference in HR, SBP and RPP before and after TENS intervention.
| Within-group difference | Between-group difference | Between-group | ||
|---|---|---|---|---|
| Acu-TENS | Placebo-TENS | |||
| Heart rate (beat min−1) | −4.50 (0.49) | 0.79 (0.21) | −5.29 (0.37) | .000 |
| SBP (mmHg) | −4.95 (0.89) | 0.35 (1.14) | −5.30 (0.85) | .206 |
| Rate pressure product | −940.9 (123.9) | 140.9 (123.6) | −1081.0 (115.2) | .010 |
Data are mean ± SE.
Mean postoperative nausea and dyspnea score before and after Acu-TENS and placebo-TENS.
| Acu-TENS group | Placebo- TENS group | Between- group | |
|---|---|---|---|
| Pre-intervention score | 0.23 ± 0.07 | 1 ± 0.19 | .001 |
| Post-intervention score | 0.09 ± 0.05 | 0.85 ± 0.18 | .000 |
| Within group | .034 | .247 |
Data are mean ± SE.
Figure 7Daily postoperative antiemetic (Maxolon) administration.
Figure 8A proposed mechanism for Acu-TENS effect on hemodynamic parameters and postoperative nausea and vomiting score (HR = heart rate; SBP = systolic blood pressure; RPP = rate pressure product; PONV = postoperative nausea and vomiting score).